Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Dexamethasone Sodium Phosphate Patent Expiration

Dexamethasone Sodium Phosphate was first introduced by Merck And Co Inc in its drug Decadron on Approved Prior to Jan 1, 1982. Other drugs containing Dexamethasone Sodium Phosphate are Dexacort, Hexadrol. 30 different companies have introduced drugs containing Dexamethasone Sodium Phosphate.


About Veterinary Dexamethasone Sodium Phosphate

Dexamethasone Sodium Phosphate is used in drugs marketed by 2 different companies: Bimeda Animal Health Limited, Cronus Pharma Specialities India Private Ltd.

Other drugs containing Dexamethasone Sodium Phosphate are: Dex a vet injection , Dexamethasone sodium phosphate inj. , Dexium sp .

Dexamethasone Sodium Phosphate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Dexamethasone Sodium Phosphate Generic API Manufacturers

Several generic applications have been filed for Dexamethasone Sodium Phosphate. The first generic version for Dexamethasone Sodium Phosphate was by Dell Laboratories Inc and was approved on Approved Prior to Jan 1, 1982. And the latest generic version is by Micro Labs Ltd and was approved on Mar 27, 2024.

Given below is the list of companies who have filed for Dexamethasone Sodium Phosphate generic, along with the locations of their manufacturing plants worldwide.